Figure 1.
Study design in patients with hematological malignancy during the study period. (non-IP group: the HM patients without IP; IP: interstitial pneumonia; IIP: infectious interstitial pneumonia; nIIP: noninfectious interstitial pneumonia).
Study design in patients with hematological malignancy during the study period. (non-IP group: the HM patients without IP; IP: interstitial pneumonia; IIP: infectious interstitial pneumonia; nIIP: noninfectious interstitial pneumonia).